What is HMPV? A new virus or global threat? quick answers
Reports appearing from China point to a noticeable rise in respiratory infections,…
Fasenra Approved in China for Severe Eosinophilic Asthma
China's National Medical Products Association (NMPA) has approved AstraZeneca’s Fasenra (benralizumab) for…
Know This: Back-to-School event focuses on Asthma education
Philadelphia- August 2024- Experts from Children’s Hospital of Philadelphia’s Center for Health…
Six-month dosing could simplify treatment to support millions of patients with severe asthma
London, UK- 23 May 2024- GSK announced positive headline results from the…